BioRestorative Therapies (BRTX) Preferred Shares (2021 - 2025)
BioRestorative Therapies' (BRTX) quarterly Preferred Shares came in at $13982.0 in Q4 2025, little changed YoY from $13982.0 in Q4 2024, and little changed on a QoQ basis from $13982.0 in Q3 2025.
BioRestorative Therapies (BRTX) Preferred Shares (2021 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 5 years of Preferred Shares data on file, last reported at $13982.0 in Q4 2025.
- Quarterly Preferred Shares changed 0.0% year-over-year to $13982.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13982.0 (changed 0.0% YoY) and the FY2025 annual result came in at $13982.0, changed 0.0% from the prior year.
- Preferred Shares held at $13982.0 in Q4 2025, from $13982.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $15432.0 in Q4 2021 to a low of $13982.0 in Q2 2023.
- A 5-year average of $14464.4 and a median of $13982.0 in 2023 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2023 — Preferred Shares retreated 9.4% — and 2024, when it changed 0.0%.
- Tracing BRTX's Preferred Shares over 5 years: stood at $15432.0 in 2021, then retreated by 1.62% to $15182.0 in 2022, then declined by 7.9% to $13982.0 in 2023, then changed by 0.0% to $13982.0 in 2024, then changed by 0.0% to $13982.0 in 2025.
- The last three Preferred Shares figures came in at $13982.0 (Q4 2025), $13982.0 (Q3 2025), and $13982.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BioRestorative Therapies | 1.94 Mn | -1.02 Mn | 17,964.00 | 13,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,982.00 |
| Sep 30, 2025 | 13,982.00 |
| Jun 30, 2025 | 13,982.00 |
| Mar 31, 2025 | 13,982.00 |
| Dec 31, 2024 | 13,982.00 |
| Sep 30, 2024 | 13,982.00 |
| Jun 30, 2024 | 13,982.00 |
| Mar 31, 2024 | 13,982.00 |
| Dec 31, 2023 | 13,982.00 |
| Sep 30, 2023 | 13,982.00 |
| Jun 30, 2023 | 13,982.00 |
| Mar 31, 2023 | 15,182.00 |
| Dec 31, 2022 | 15,182.00 |
| Sep 30, 2022 | 15,432.00 |
| Jun 30, 2022 | 15,432.00 |
| Mar 31, 2022 | 15,432.00 |
| Dec 31, 2021 | 15,432.00 |